Notably, exogenous IL‐10 administration significantly attenuated aortic wall inflammation in rabbit AAA models through immunomodulatory reprogramming of Th1/Th2 cytokine balance, ultimately retarding aneurysmal progression as evidenced by reduced expansion rates and preserved medial integrity [29]. Here, IL10 is linked to triple-A syndrome.